Clinical Trial Update: Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating fezolinetant for hot flashes in men with prostate cancer receiving androgen deprivation therapy, and the study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Fezolinetant (fezolinetant)

Snippet

Sponsor: University of Vermont | Conditions: Prostate CA, Androgen Deprivation Therapy | Phase 2 | Status: RECRUITING